| __timestamp | BioCryst Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 18372000 |
| Thursday, January 1, 2015 | 72758000 | 15419000 |
| Friday, January 1, 2016 | 61008000 | 23844000 |
| Sunday, January 1, 2017 | 66962000 | 40376000 |
| Monday, January 1, 2018 | 84888000 | 75247000 |
| Tuesday, January 1, 2019 | 107068000 | 89017000 |
| Wednesday, January 1, 2020 | 122964000 | 114764000 |
| Friday, January 1, 2021 | 208808000 | 113864000 |
| Saturday, January 1, 2022 | 253297000 | 130991000 |
| Sunday, January 1, 2023 | 216566000 | 184353000 |
Data in motion
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Corcept Therapeutics Incorporated and BioCryst Pharmaceuticals, Inc. have demonstrated a steadfast commitment to advancing medical science.
BioCryst Pharmaceuticals has shown a remarkable 400% increase in R&D spending from 2014 to 2023. This surge underscores their dedication to pioneering treatments, particularly in the realm of rare diseases.
Corcept Therapeutics, while starting with lower R&D investments, has increased its spending by over 900% during the same period. This strategic allocation of resources highlights their focus on developing therapies for psychiatric and metabolic disorders.
Both companies exemplify the dynamic nature of the biotech industry, where strategic R&D investments pave the way for groundbreaking therapies and improved patient outcomes.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.